Ana M Aransay Selected Research

Ana M Aransay Research Topics

Disease

15	Neoplasms (Cancer) 01/2024 - 04/2008
7	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 05/2015
5	Fibrosis (Cirrhosis) 01/2022 - 04/2008
4	Fatty Liver 01/2023 - 04/2008
4	Inflammation (Inflammations) 01/2022 - 01/2018
3	Non-alcoholic Fatty Liver Disease 11/2017 - 02/2013
3	Ankylosing Spondylitis 06/2013 - 11/2011
2	Liver Neoplasms (Liver Cancer) 03/2024 - 04/2008
2	Carcinogenesis 01/2023 - 07/2015
2	Hepatocellular Carcinoma (Hepatoma) 09/2012 - 04/2008
1	Crohn Disease (Crohn's Disease) 10/2023
1	Hypoxia (Hypoxemia) 10/2023
1	Ulcerative Colitis 10/2023
1	Colitis 10/2023
1	Disease Progression 10/2023
1	Melanoma (Melanoma, Malignant) 02/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Neurofibrosarcoma (MPNST) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Cholangiocarcinoma 01/2020
1	Glioma (Gliomas) 12/2019
1	Fibromyalgia (Fibrositis) 08/2019
1	7 Hereditary Prostate Cancer 01/2018
1	Cholestasis 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Thymoma (Thymic Carcinoma) 07/2015
1	Premature Aging 04/2014
1	Infections 02/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2014
4	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2014
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2017
3	EnzymesIBA 01/2022 - 04/2008
3	Messenger RNA (mRNA)IBA 01/2020 - 04/2008
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2024 - 01/2020
2	AntigensIBA 03/2024 - 05/2012
2	MethyltransferasesIBA 01/2024 - 12/2019
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 10/2023 - 01/2022
2	Transfer RNA (tRNA)IBA 10/2023 - 01/2023
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2021
2	ProteomeIBA 12/2019 - 11/2017
2	CytokinesIBA 08/2019 - 04/2008
2	MicroRNAs (MicroRNA)IBA 08/2019 - 01/2018
2	PolyaminesIBA 01/2018 - 01/2017
2	Methionine (L-Methionine)FDA Link 11/2017 - 04/2008
2	S-Adenosylmethionine (Ademetionine)IBA 01/2017 - 09/2012
2	prelamin AIBA 04/2014 - 04/2012
2	HLA-DPA1 antigen (HLA DPA1)IBA 06/2013 - 11/2011
2	Glycine N-Methyltransferase (Glycine Sarcosine N-Methyltransferase)IBA 09/2012 - 04/2008
1	Long Noncoding RNAIBA 10/2023
1	AngiomotinsIBA 10/2023
1	AsparagineIBA 10/2023
1	Mixed Function Oxygenases (Monooxygenases)IBA 10/2023
1	Immunoglobulin A (IgA)IBA 10/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023
1	InflammasomesIBA 02/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Tricarboxylic AcidsIBA 01/2022
1	CateninsIBA 01/2020
1	Cytostatic AgentsIBA 01/2020
1	5-Methylcytosine (5 Methylcytosine)IBA 12/2019
1	Glutamic Acid (Glutamate)FDA Link 08/2019
1	Microphthalmia-Associated Transcription FactorIBA 10/2018
1	Crystallins (Crystallin)IBA 10/2018
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	Simvastatin (Zocor)FDA LinkGeneric 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	LigandsIBA 01/2018
1	Trefoil FactorsIBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	A-Form DNA (A-DNA)IBA 01/2018
1	Choline (Choline Chloride)IBA 11/2017
1	aramcholIBA 11/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	S-adenosyl-3-methylthiopropylamineIBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	Methionine AdenosyltransferaseIBA 01/2017
1	Cadherins (E-Cadherin)IBA 02/2016
1	Mechanistic Target of Rapamycin Complex 2IBA 07/2015
1	TOR Serine-Threonine KinasesIBA 07/2015
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 07/2015
1	DNA (Deoxyribonucleic Acid)IBA 03/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2013
1	AntioxidantsIBA 02/2013
1	LipidsIBA 02/2013
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 02/2013
1	Phosphotransferases (Kinase)IBA 09/2012
1	Peptides (Polypeptides)IBA 09/2012
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 09/2012
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 09/2012
1	Adenosine (Adenocard)FDA LinkGeneric 09/2012

Therapy/Procedure

4	Therapeutics 10/2023 - 04/2012
1	Biological Therapy 10/2023
1	Fecal Microbiota Transplantation 10/2023
1	Drug Therapy (Chemotherapy) 10/2023
1	Immunotherapy 01/2023
1	Ligation 01/2018